Bone cement study for revision joint surgery withdrawn before start
NCT ID NCT06699160
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to check the safety and performance of Refobacin Revision-3 Bone Cement when used in hip or knee revision surgeries. It aimed to track how often metal implants needed to be removed, any side effects, and changes in pain, function, and quality of life. However, the study was withdrawn before any participants were enrolled, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Refobacin Revision-3 Bone Cement
- What this could lead to
- If successful, this study could confirm that the cement is safe and effective for use in hip or knee revision surgeries.
- What could go wrong
- The study was withdrawn before enrolling any participants, so no data will be collected. This means we cannot draw any conclusions from it.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTION OF HIP OR KNEE PROSTHESIS BY GENTAMICIN AND/OR CLINDAMYCIN SENSITIVE STRAINS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Diakonessenhuis UMC Utrecht
Utrecht, 3582, Netherlands